Brain Amylin Signaling, Feeding, and Reward. [PDF]
Compr PhysiolMietlicki-Baase EG.
europepmc +1 more source
Recent developments in GPCR signalling in appetite regulation. [PDF]
Biosci RepBrittain HR, Gorvin CM.
europepmc +1 more source
Targeting a metabolic OA in vivo model by a novel dual amylin calcitonin receptor agonist, KBP-056 [PDF]
Osteoarthritis and Cartilage, 2016 Reker, D. +6 more
openaire +1 more source
Hypothalamus-liver talks: whispers in the language of metabolism. [PDF]
Rev Endocr Metab DisordFerreira V +5 more
europepmc +1 more source
Management of Obese Patients with Cardiovascular Disease with Emerging Weight-Lowering Drugs: A Narrative Review. [PDF]
BiomedicinesCiarloni A +4 more
europepmc +1 more source
Do no harm: managing nausea and vomiting in GLP-1 based obesity therapies. [PDF]
Front Endocrinol (Lausanne)Alhazmi A, le Roux CW.
europepmc +1 more source
Not only gut feelings: pancreatic hormone, amylin, controls emotionality and sociability, in a sex divergent manner. [PDF]
Transl PsychiatryByun S +5 more
europepmc +1 more source
Assessment of Weight Loss by Amylin Receptor Agonists Alone and In Combination with GLP-1 Receptor Agonists: A Model-Based Meta-AnalysisSima Ahadieh +4 more
openaire +1 more source
Toxicological profile of anti-diabetic drugs and emerging measures to reduce the toxic burden. [PDF]
Toxicol RepDugbartey GJ +5 more
europepmc +1 more source
Incretin polyagonists as an alternative to bariatric surgery to manage obesity. [PDF]
World J Gastrointest PathophysiolManoj RJ +3 more
europepmc +1 more source